In the 1970s, the combined work of the late, Stanford-based immunologist, Len Herzenberg, and Becton, Dickinson and Company (BD) turned flow cytometry into a commercial platform — the FACS-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback